Skip to content

BZAI BZAI Non-cash financing expense related to issuance of common stock

Non-cash financing expense related to issuance of common stock at other companies

Rayonier Advanced Materials logo
Rayonier Advanced MaterialsRYAM
$0-100%
LON
LeonaBio, Inc. Common StockLONA
$1.89M
TransDigm Group logo
TransDigm GroupTDG
$12M+20.0%
comScore logo
comScoreSCOR
$907K
NTS
Netskope, Inc. Class A Common StockNTSK
$0-100%
Kyverna Therapeutics, Inc. logo
Kyverna Therapeutics, Inc.KYTX
$69K-9.2%

Other financials

Income statement

See full
Revenue$2.7M+172%
Gross profit$1.6M+132%
Operating income-$23.4M+38.5%
Net income-$22.7M+84.7%
EPS (diluted)-$0.19+88.2%

Balance sheet

See full
Cash & equivalents$33.5M-26.0%
Total debt$1.2M-22.4%
Total equity$25.4M+52.3%
Total assets$70.8M-29.4%

Cash flow

See full
Operating cash flow-$12.6M+20.8%
CapEx$116.0K-82.5%
Free cash flow-$12.7M+23.2%

Valuation

See full
Market cap$196.37M-29.3%
Enterprise value$164.13M-34.5%
P/S4.9×-68.8×

Profitability

See full
Gross margin17.6%-52.6pp
Operating margin-221%-107pp
Net margin-202.7%-100pp
FCF margin-175.1%-85.1pp

Returns & leverage

See full
Return on equity-388.1%
Debt / equity0.0×
Current ratio2.5×0.0×

Where this comes from

Reported directly by BZAI in its filing.

Tagged under the XBRL concept blz:NoncashFinancingExpenseIssuanceOfCommonStock.

The official record: BZAI’s 10-K, filed March 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about BZAI's non-cash financing expense related to issuance of common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BZAI's non-cash financing expense related to issuance of common stock?
BZAI (BZAI) reported non-cash financing expense related to issuance of common stock of $691.75K in Q4 2025.
What does non-cash financing expense related to issuance of common stock mean?
Captures the non-cash accounting impact associated with the issuance of equity instruments, often related to services rendered or financing arrangements. This adjustment reconciles net income by removing expenses that do not involve an actual cash outflow to shareholders. It is essential for understanding the true cash-based cost of capital raising activities.